TUMOUR TESTING IS REQUIRED TO DETECT SOMATIC BRCA1/2 MUTATIONS

[1]

[1]

• Pennington KP et al. Clin Cancer Res 2014;20:764–75 [Supplementary Table 1]
• Yates et al. Next generation sequencing of BRCA1/2 in high grade ovarian tumors expand BRCA defects beyond germline mutations. Poster presented at ESMO 2014